Amneal Pharmaceuticals, Inc. cotiza a 19.57 USD y tiene una capitalización bursátil de $6.8B. En los últimos 12 meses ha facturado $3.1B con un margen de flujo de caja libre del 8.9%. Cotiza a 53.3 veces su flujo de caja libre (P/FCF) y a un PER de 43.3. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Amneal Pharmaceuticals, Inc., a global biopharmaceutical company, develops, manufactures, markets, and distributes generics, injectables, biosimilars, and specialty branded pharmaceutical products in the United States, India, Ireland, and internationally. The company operates through three segments: Affordable Medicine…
| Periodo | 2026-11 | 2026-07 | 2026-05 | 2026-05 |
|---|---|---|---|---|
| Real | — | $0.30 | $0.27 | — |
| Estimado | $0.23 | $0.23 | $0.17 | $0.17 |
| Sorpresa | — | +30.4% | +58.8% | — |
| Métrica | AMRX | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 36.9% | 57.0% | -20.2% |
| Operating Margin | 13.1% | -38.6% | +51.7% |
| Net Margin | 2.4% | -33.6% | +36.0% |
| FCF Margin | 8.9% | -13.9% | +22.8% |
| ROE | — | -40.4% | — |
| ROA | 2.0% | -32.0% | +34.0% |
| Current Ratio | 2.17 | 2.84 | -0.67 |
| Debt / Equity | -36.33 | 0.28 | -36.61 |